CANCER

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

Published 07/12/2019

(Reuters) - Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the [more…]

Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Bristol-Myers reports positive data on cancer treatment acquired in Celgene deal

Published 07/12/2019

(Reuters) - Bristol-Myers Squibb Co on Saturday said that an experimental cancer therapy it acquired as part of its $74 billion deal for Celgene Corp [more…]

Bristol-Myers, bluebird therapy for multiple myeloma succeeds in mid-stage trial

Bristol-Myers, bluebird therapy for multiple myeloma succeeds in mid-stage trial

Published 06/12/2019

(Reuters) - Bristol-Myers Squibb Co and bluebird bio Inc said on Friday their experimental therapy for a type of multiple myeloma met the main goal [more…]

Sanofi pulls Zantac from U.S. and Canada after carcinogen found

Sanofi pulls Zantac from U.S. and Canada after carcinogen found

Published 18/10/2019

NEW YORK (Reuters) - Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines [more…]

In new headache, WeWork says it found cancer-causing chemical in its phone booths

In new headache, WeWork says it found cancer-causing chemical in its phone booths

Published 14/10/2019

NEW YORK (Reuters) - Cash-strapped WeWork, the office-sharing company that is trying to negotiate a financial lifeline, has a new problem that may prove costly. [more…]

Results of GSK and AstraZeneca trials may widen ovarian cancer drug use

Results of GSK and AstraZeneca trials may widen ovarian cancer drug use

Published 28/09/2019

BARCELONA (Reuters) - GlaxoSmithKline and AstraZeneca both reported trial results that will likely make their competing drugs available to a wider group of ovarian cancer [more…]

Targeted Amgen drug has low response rate in colon cancer in study

Targeted Amgen drug has low response rate in colon cancer in study

Published 28/09/2019

(Reuters) - An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in just one of 12 patients with advanced colorectal cancer [more…]

PTSD linked to increased risk of ovarian cancer

PTSD linked to increased risk of ovarian cancer

Published 13/09/2019

(Reuters Health) - Women who exhibit many classic symptoms of post-traumatic stress disorder (PTSD) may be much more likely to develop ovarian cancer than their [more…]

Cancer doctors don’t focus on lifestyle risks

Cancer doctors don’t focus on lifestyle risks

Published 26/08/2019

(Reuters Health) - Cancer specialists only rarely advise patients on lifestyle changes that could improve overall health and possibly also reduce the risk of recurrence, [more…]

As Americans get heavier, obesity-linked cancers may strike earlier

As Americans get heavier, obesity-linked cancers may strike earlier

Published 16/08/2019

Increasing numbers of middle-aged Americans appear to be developing cancers that can be associated with obesity, new data suggest. And the increase in these cancers [more…]